Quantitative Imaging in Radionuclide Therapy with Lutetium-177 : Towards Traceability and Comparability
Radionuclide therapy involving 177Lu-labelled somatostatin analogues for the treatment of neuroendocrine tumours isincreasing. While the treatment is currently administered according to a standard protocol, patient-specific treatmentsbased on dosimetry are believed to be beneficial. However, commonly adopted dosimetry procedures are lacking, andlocally developed dosimetry methods are used, which m
